Glutathione has a bright future

 There are mainly injection powder and oral dosage forms. The product also has the functions of curing eye diseases, such as early age-related cataract, corneal ulcers, keratitis, repairing cornea or lens transparency. Its applications are increasingly widespread. In recent years, population aging in China promotes the market development of glutathione.

There are many clinical drugs for curing the hepatobiliary system. They are anti-hepatitis C virus drugs, liver disease, adjuvant treatment of hepatic coma drugs, composed of four series of the choleretic drugs. Glutathione with broad-spectrum detoxification, reduced glutathione is widely distributed in various organs within the body, clinical for viral, drug toxicity, alcohol toxicity, and other chemicals caused by toxic liver damage, but also adjuvant therapy in cancer patients with radiation therapy, chemotherapy drugs, acute anemia, adult respiratory distress syndrome, sepsis, combination therapy has a positive effect.

At present, China glutathione bulk drugs, though still in research and development, has been a breakthrough. Glutathione raw materials, mass production technology development has been the country strongly supports the project. Glutathione production process is fermentation, enzymatic conversion method and chemical synthesis. Today, chemical synthesis and extraction of industrialization, the enzymatic conversion of undergoing extensive development. Industrial scale production is a key link in the next step.

The clinical glutathione in reducing brain tissue ischemia and reperfusion injury show a certain role. Resveratrol and glutathione can be used to improve the adjuvant treatment of patients with acute stroke, has a protective effect on the heart. At the same time, glutathione is a better efficacy of eye drops. According to statistics, in recent years, dry eye patients have a rapid increase in the rate from 10% to 20% per year. The population incidence of up to 30%. Number of myopia prevalence is increasing year by year,

And the growing trend of younger age. Of both diseases has provided a vast market for artificial tears, eye drops and other medicines. The same time, the glutathione of the drug's active ingredient, glutathione, and participation in the intracellular redox processes, revitalizes plays an SH enzyme, coenzyme role, can prevent UV-induced cataract and inhibition of corneal ulcers. And control progressive development of cataracts and retinopathy. In 2009, the China ophthalmic sales of 6.165 billion RMB, an increase of 10 percent over the same period last year. The sale of drugs is still anti-infective, anti-dry eye disease, anti-glaucoma-based. In addition, glutathione as the biological activity of enhancer, the use of food additives are also increasingly subject to people's attention abroad have been developed related to functional foods.

In summary, glutathione is a considerable market potential variety like plant extracts. It is not only playing a good role in anti-hepatitis C virus drugs, liver disease, adjuvant and ophthalmic field, the medical profession has begun to study the application of cardiovascular and circulatory system. With the deepening study of peptide, the amazing features of peptide continue to be found. Glutathione will become an important specie.Source:http://www.cospcn.com